Trial Profile
A Phase 2,Double-Blind, Randomized, Placebo-Controlled, Dose Escalating, Multicenter Study of SGX942 For the Attenuation of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Dusquetide (Primary)
- Indications Stomatitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Soligenix
- 29 Aug 2018 According to a Soligenix media release, data from this trial will be presented at the 2018 ESCMID/ASM Conference.
- 04 Jun 2018 According to a Soligenix media release, data from this trial will be presented at the 2018 American Society of Microbiology Microbe Conference.
- 09 Nov 2017 According to a Soligenix media release, results from this trial will be presented at the 2nd Annual Superbugs & Superdrugs USA Conference.